News and Trends 20 Jul 2016
Israeli Biopharma joins NIH to develop Ebola Treatment
…assess disease severity, through markers like viral loads and cytokine levels. RedHill’s main focus is gastrointestinal diseases, having different clinical programs with antibiotics to tackle its causes. (Source: RedHill Biopharma)…